Skip to main content
Erschienen in: The journal of nutrition, health & aging 5/2020

14.04.2020

Cardiac Manifestations of Sarcopenia

verfasst von: X. Yang, Jean Woo, L. Ting Lui, Q. Li, K. Fai Cheng, Y. Fan, F. Yau, A. P. W. Lee, J. S. W. Lee, E. Fung

Erschienen in: The journal of nutrition, health & aging | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Screening questions for sarcopenia used in the community (SARC-F) may be regarded as indicators of exercise tolerance.

Design

Observational study.

Setting

We tested the hypothesis that community-living older people who are screened positive for sarcopenia using the SARC-F tool but without a history of heart failure (HF) have a higher prevalence of cardiac abnormalities compared with those who are SARC-F negative.

Participants

Participants were recruited from a territory-wide primary care needs assessment for older people based in community centres, and from non-acute hospitals in the same region as the study centre.

Measurements

Participants with a total score of >=4 and who did not have any history of HF were invited to attend for further cardiac assessment. Grip strength, walking speed, and the 6-minute walk test and echocardiography were carried out. Patients with frailty and at least Grade II diastolic dysfunction were considered to have heart failure with preserved ejection fraction (HFpEF) if they also had concomitant elevated N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) of at least 300 pg/ml.

Results

Diastolic dysfunction (DD) was significantly associated with SARC-F score >=4 and higher circulating NT-proBNP levels. ROC curves evaluating the predictive values of SARC-F, HGS and gait speed for DD showed that a combination of SARC-F and HGS or gait speed provided significant incremental value in predicting DD.

Conclusions

Community living older people with sarcopenia detected using a simple questionnaire have a higher prevalence of DD accompanied by elevated NT proBNP. Addition of hand grip strength or walking speed improve the magnitude of the association. SARC-F may be used as a tool to detect early cardiac dysfunction in the community.
Literatur
1.
Zurück zum Zitat Rosenberg IH. Sarcopenia: Origins and clinical relevance. J Nutr. 1997;127:S990–S1.CrossRef Rosenberg IH. Sarcopenia: Origins and clinical relevance. J Nutr. 1997;127:S990–S1.CrossRef
2.
13.
Zurück zum Zitat Tsuchida K, Fujihara Y, Hiroki J, et al. Significance of Sarcopenia Evaluation in Acute Decompensated Heart Failure. Int Heart J. 2018;S9(1): 143–8. doi: 10.1536/ihj.17-057CrossRef Tsuchida K, Fujihara Y, Hiroki J, et al. Significance of Sarcopenia Evaluation in Acute Decompensated Heart Failure. Int Heart J. 2018;S9(1): 143–8. doi: 10.1536/ihj.17-057CrossRef
16.
Zurück zum Zitat Cheung JTK, Yu R, Wu Z, Wong SYS, Woo J. Geriatric syndromes, multimorbidity, and disability overlap and increase healthcare use among older Chinese. Bmc Geriatr. 2018;18(1):147.CrossRef Cheung JTK, Yu R, Wu Z, Wong SYS, Woo J. Geriatric syndromes, multimorbidity, and disability overlap and increase healthcare use among older Chinese. Bmc Geriatr. 2018;18(1):147.CrossRef
18.
Zurück zum Zitat Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. doi:https://doi.org/10.1016/j.echo.2016.01.011 CrossRef Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. doi:https://​doi.​org/​10.​1016/​j.​echo.​2016.​01.​011 CrossRef
19.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2016;37(27):2129–200. doi:https://doi.org/10.1093/eurheartj/ehw128 CrossRef Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2016;37(27):2129–200. doi:https://​doi.​org/​10.​1093/​eurheartj/​ehw128 CrossRef
24.
Zurück zum Zitat Landi F, Calvani R, Cesari M, et al. Sarcopenia as the Biological Substrate of Physical Frailty. Clin Geriatr Med. 2015;31(3):367–74.CrossRef Landi F, Calvani R, Cesari M, et al. Sarcopenia as the Biological Substrate of Physical Frailty. Clin Geriatr Med. 2015;31(3):367–74.CrossRef
Metadaten
Titel
Cardiac Manifestations of Sarcopenia
verfasst von
X. Yang
Jean Woo
L. Ting Lui
Q. Li
K. Fai Cheng
Y. Fan
F. Yau
A. P. W. Lee
J. S. W. Lee
E. Fung
Publikationsdatum
14.04.2020
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 5/2020
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-020-1358-8

Weitere Artikel der Ausgabe 5/2020

The journal of nutrition, health & aging 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.